Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology
暂无分享,去创建一个
Ingo Roeder | Ingmar Glauche | Markus Loeffler | Thomas Ernst | Markus Scholz | Yuri Kheifetz | Andreas Hochhaus | Katja Hoffmann | Katja Cazemier | Christoph Baldow | Silvio Schuster | Sibylle Schirm | Matthias Horn | Constanze Volgmann | Christian Thiede | Martin Bornhäuser | Meinolf Suttorp | M. Scholz | M. Loeffler | I. Glauche | Y. Kheifetz | I. Roeder | C. Thiede | A. Hochhaus | M. Bornhäuser | M. Suttorp | T. Ernst | S. Schirm | M. Horn | Christoph Baldow | C. Volgmann | Katja Hoffmann | Katja Cazemier | Silvio Schuster
[1] Markus Scholz,et al. Modeling individual time courses of thrombopoiesis during multi-cyclic chemotherapy , 2019, PLoS Comput. Biol..
[2] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[3] Fabian Prasser,et al. A generic solution for web-based management of pseudonymized data , 2015, BMC Medical Informatics and Decision Making.
[4] Michael Schroeder,et al. MAGPIE: Simplifying access and execution of computational models in the life sciences , 2017, PLoS Comput. Biol..
[5] Markus Scholz,et al. A biomathematical model of human thrombopoiesis under chemotherapy. , 2010, Journal of theoretical biology.
[6] Markus Löffler,et al. Modelling chemotherapy effects on granulopoiesis , 2014, BMC Systems Biology.
[7] I. Glauche,et al. Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data , 2018, Haematologica.
[8] M. Baccarani,et al. Chronic myeloid leukaemia , 2007, The Lancet.
[9] Dirk Hasenclever,et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. , 2004, Blood.
[10] I. Glauche,et al. Quantitative prediction of long-term molecular response in TKI-treated CML – Lessons from an imatinib versus dasatinib comparison , 2018, Scientific Reports.
[11] M. Pfreundschuh,et al. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] Anna-Karin Hamberg,et al. A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children , 2015, BMC Medical Informatics and Decision Making.
[13] Anca I. D. Bucur,et al. Workflow-driven clinical decision support for personalized oncology , 2016, BMC Medical Informatics and Decision Making.
[14] Markus Scholz,et al. A Biomathematical Model of Human Erythropoiesis under Erythropoietin and Chemotherapy Administration , 2013, PloS one.
[15] Markus Scholz,et al. Model-based optimization of G-CSF treatment during cytotoxic chemotherapy , 2017, Journal of Cancer Research and Clinical Oncology.
[16] M. Scholz,et al. A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment , 2014, Theoretical Biology and Medical Modelling.
[17] Inigo Martincorena,et al. Precision oncology for acute myeloid leukemia using a knowledge bank approach , 2017, Nature Genetics.
[18] Nicola D. Roberts,et al. Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline. , 2014, Blood.
[19] Jeffrey S. Barrett,et al. Bmc Medical Informatics and Decision Making Integration of Modeling and Simulation into Hospital-based Decision Support Systems Guiding Pediatric Pharmacotherapy , 2008 .
[20] Martin C. Müller,et al. Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia. , 2013, Blood.
[21] Tsai-Chung Li,et al. Development of a real-time clinical decision support system upon the web mvc-based architecture for prostate cancer treatment , 2011, BMC Medical Informatics Decis. Mak..
[22] Dirk Hasenclever,et al. Modeling combined chemo- and immunotherapy of high-grade non-Hodgkin lymphoma , 2016, Leukemia & lymphoma.
[23] James Lyons-Weiler,et al. Clinical decision modeling system , 2007, BMC Medical Informatics Decis. Mak..
[24] Ingo Roeder,et al. Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications , 2006, Nature Medicine.